Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.

Saved in:
Bibliographic Details
Title: Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Authors: Burdett S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK. Electronic address: sarah.burdett@ucl.ac.uk., Fisher DJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK., Tierney JF; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK., Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK; Clinical Effectiveness Unit, Royal College of Surgeons of England, London, UK., Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Dignam JJ; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA., Seiferheld WF; NRG Oncology, Philadelphia, PA, USA., Kishan AU; Radiation Oncology, Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, CA, USA., Sun Y; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA., Chabaud S; Clinical Research Unit, Centre Léon Bérard, Lyon, France., Efstathiou JA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Parker CC; Department of Urology, The Royal Marsden Hospital (Sutton) - NHS Foundation Trust, Sutton, UK; Institute of Cancer Research, Sutton, UK., Pollack A; Department of Radiation Oncology, Miller School of Medicine and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Sargos P; Department of Radiotherapy, Institute Bergonié, Bordeaux, France., Latorzeff I; Department of Radiation Oncology, Clinique Pasteur, Toulouse, France., Brihoum M; R&D, Unicancer, Paris, France., Catton CN; Radiation Oncology Department, Princess Margaret Cancer Center, Toronto, Canada., Clarke NW; Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester, UK., Feng FY; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, USA., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA., Pommier P; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France., Sandler HM; Cedars Sinai Medical Center, Los Angeles, CA, USA., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK; Transformation Directorate, NHS England, London, UK., Vale CL; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
Corporate Authors: DADSPORT Meta-analysis Collaboration
Source: European urology [Eur Urol] 2025 Sep; Vol. 88 (3), pp. 277-290. Date of Electronic Publication: 2025 Jun 26.
Publication Type: Journal Article; Network Meta-Analysis; Systematic Review
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2025.05.013